BALANCE SHEETS - USD ($)	Jun. 30, 2019	Sep. 30, 2018
CURRENT ASSETS:
Cash and cash equivalents	$ 9,485,495	$ 10,310,044
Receivables	118,264	118,657
Prepaid expenses	233,784	364,622
Inventory used for R&D and manufacturing	754,825	645,238
Total current assets	10,592,368	11,438,561
Plant, property and equipment, net	15,948,864	16,218,851
Patent costs, net	272,488	258,093
Deposits	1,670,917	1,670,917
Total Assets	28,484,637	29,586,422
CURRENT LIABILITIES:
Accounts payable	2,078,800	5,743,913
Accrued expenses	122,030	205,310
Due to employees	761,027	764,941
Derivative instruments, current portion	1,249,835	2,498,606
Other current liabilities	16,009	14,029
Total current liabilities	4,227,701	9,226,799
Derivative instruments - net of current portion	9,482,995	6,818,458
Lease Liability	13,475,704	13,379,962
Deferred income	126,849	126,795
Other liabilities	25,084	33,492
Total liabilities	27,338,333	29,585,506
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 34,066,914 and 28,034,487 shares issued and outstanding at June 30, 2019 and September 30, 2018, respectively	340,669	280,346
Additional paid-in capital	349,683,796	331,312,184
Accumulated deficit	(348,878,161)	(331,591,614)
Total stockholders' equity	1,146,304	916
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 28,484,637	$ 29,586,422